Skip to main content
Clinical Trials/NCT04011332
NCT04011332
Completed
Not Applicable

Nurse-led Integrated Care to Improve Quality of Life in COPD Patients With a Pulmonary Exacerbation

University of Zurich1 site in 1 country69 target enrollmentJuly 4, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD Exacerbation
Sponsor
University of Zurich
Enrollment
69
Locations
1
Primary Endpoint
Change in CRQ (Chronic Respiratory Questionnaire) scores
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of the study is to evaluate the effect and effectiveness of the nurse-led integrated care programme for the management of COPD (Chronic Obstructive Pulmonary Disease) exacerbations on patients' quality of life, rehospitalisation and exacerbation rate, illness-related emotional distress, selected health behaviours and cost-utility at three months. Furthermore, understanding barriers and facilitators to implementation success is of interest.

Registry
clinicaltrials.gov
Start Date
July 4, 2019
End Date
April 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with a confirmed diagnosis of COPD (GOLD 1-4)
  • Hospitalisation due to a COPD exacerbation and decision to start with steroids and/or antibiotics (severe exacerbation)

Exclusion Criteria

  • Cognitive impairment (dementia, delirium)
  • Not speaking German, French, Italian, English, Spanish, Portuguese, Serbian, Tamil, Hindi, Turkish or Slovakian

Outcomes

Primary Outcomes

Change in CRQ (Chronic Respiratory Questionnaire) scores

Time Frame: at week one and week 13

Change in the four CRQ (Chronic Respiratory Questionnaire) subscores from week 1 to 13. The self-administered questionnaire version with standardised dyspnea questions (SAS) will be used. The questionnaire was developed for patients with chronic airflow limitations and comprises 20 items which assess four domains: 1) dyspnea, 2) fatigue, 3) emotional function and 4) mastery. The scoring scale ranges from 1 (extreme) to 7 (not at all) and will be assessed with a recall period of the past 2 weeks. A subscore for each domain (sum of items / number of items) will be calculated.

Study Sites (1)

Loading locations...

Similar Trials